Dieter Saur
Geboren:
1968
Hat mitgewirkt an:
-
The contribution of epithelial to mesenchymal transition (EMT) to the metastases of pancreatic cancer
-
Pharmaco-genetic screening identifies novel targets and multimodal therapeutic strategies for pancreatic cancer subtypes
-
Next-generation in vivo models for improved pancreatic cancer therapies
-
An automated high-throughput drug screen for the identification of therapeutic vulnerabilities in pancreatic cancer cell lines